Screenings of amyloid beta production inhibitor via suppression of intracellular amyloid precursor protein trafficking.
| Project/Area Number |
25830041
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Nerve anatomy/Neuropathology
|
|---|
| Research Institution | Doshisha University |
|---|
Principal Investigator |
URANO Yasuomi 同志社大学, 生命医科学部, 助教 (00546674)
|
|---|
| Project Period (FY) |
2013-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2013: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
|---|
| Keywords | 神経変性疾患 / アルツハイマー病 / 細胞内輸送 / クルクミン / 脂質代謝 / 酸化ステロール |
|---|
| Outline of Final Research Achievements |
A major pathological hallmark of Alzheimer’s disease is the accumulation of Amyloid β (Aβ) in senile plaques. Aβ is generated from Amyloid precursor protein (APP) by cleavage with secretases. In this study, I found that the treatment with 24S-hydroxycholesterol, which is the brain-specific oxysterol, inhibited Aβ production by suppression of intracellular transport of APP from the endoplasmic reticulum to the Golgi.
I also conducted in vitro screening of curcumin derivatives. I identified compound which inhibited Aβ production without affecting secretase activities via suppression of intracellular APP trafficking.
|
Report
(3 results)
Research Products
(10 results)
